References
1. Lamas A., et al., Microbiol Res., 206, 60-73
(2018).
2. O'Regan E., et al., Antimicrobial agents and
chemotherapy 54.1, 367-374 (2010).
3. Frost JA., et al., Journal of Antimicrobial
A., et al. 2004. Blood 105, 2324.
InSolution™ IKK-2 Inhibitor, SC-514
A 25 mM (1 mg/178 ml) solution of IKK-2 Inhibitor,
SC-514 (Cat. No. 401479) in DMSO. A cell-permeable,
potent, reversible, ATP-competitive
labelling of lymphocytes
for studies of cell migration in vivo.
Scand.J.Immunol. 1997; 45: 511-514.
28. Kaneda R, Iwabuchi K, Onoe K: Dissociation
of Fas-mediated cytotoxicity and FasL
expression
Karin, M., et al. 2004. Nat. Rev. Drug Dis. 3, 17; Greten, F.R., and Karin, M. 2004. Cancer Lett. 206, 193; Jones, W.K., et al. 2003. Cardiovasc. Toxicol. 3
229; Richmond, A. 2002. Nat. Rev. Immunol
Endothelial ( e-NOS) N3893 P y y y
513 Nitric Oxide Synthase, Endothelial ( e-NOS) N2643 P y y n/d
514 Nitric Oxide Synthase, Inducible (i-NOS) N7782 P n/d y y
515 Nitric Oxide Synthase, Inducible (i-NOS
Oxide Synthase, Endothelial ( e-NOS) N2643 18127, 4846 NOS3,Nos3 NP_032739.3,NP_000594.2 P y y n/d
514 Nitric Oxide Synthase, Inducible (i-NOS) N7782 18126, 24599 Nos2 NP_035057.1,NP_036743.3 P n/d y y
Oxide Synthase, Endothelial ( e-NOS) N2643 18127, 4846 NOS3,Nos3 NP_032739.3,NP_000594.2 P y y n/d
514 Nitric Oxide Synthase, Inducible (i-NOS) N7782 18126, 24599 Nos2 NP_035057.1,NP_036743.3 P n/d y y